BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Replimune Group
REPL
$1.01B
| $13.4M | ﹤0.01% |
933,709
-135,409
| -13% | -$1.95M |
|
|
PHX
3102
DELISTED
PHX Minerals
PHX
| $13.3M | ﹤0.01% |
1,189,996
+7,034
| +0.6% | +$92.4K |
|
3103
MVB Financial
MVBF
$389M
| $13.3M | ﹤0.01% |
533,115
+12,538
| +2% | +$266K |
|
3104
Red River Bancshares
RRBI
$659M
| $13.3M | ﹤0.01% |
236,484
+202,718
| +600% | +$9.66M |
|
3105
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$148M
| $13.2M | ﹤0.01% |
421,811
+27,426
| +7% | +$896K |
|
3106
Ribbon Communications
RBBN
$383M
| $13.2M | ﹤0.01% |
4,245,541
+169,743
| +4% | +$676K |
|
|
CBMG
3107
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $13.2M | ﹤0.01% |
810,082
+32,720
| +4% | +$546K |
|
3108
BayCom
BCML
$333M
| $13.1M | ﹤0.01% |
574,142
+7,205
| +1% | +$159K |
|
3109
PCB Bancorp
PCB
$391M
| $13.1M | ﹤0.01% |
755,294
+5,590
| +0.7% | +$94K |
|
|
AT
3110
DELISTED
Atlantic Power Corporation
AT
| $13M | ﹤0.01% |
5,598,601
-17,515
| -0.3% | -$41.5K |
|
|
ONIT
3111
Onity Group
ONIT
$332M
| $13M | ﹤0.01% |
634,311
+7,958
| +1% | +$193K |
|
3112
Natural Gas Services Group
NGS
$477M
| $13M | ﹤0.01% |
1,056,680
+35,214
| +3% | +$415K |
|
|
SNCR
3113
DELISTED
Synchronoss Technologies
SNCR
| $12.9M | ﹤0.01% |
302,765
+14,974
| +5% | +$665K |
|
|
JPUS
3114
JPMorgan Diversified Return US Equity ETF
JPUS
$465M
| $12.9M | ﹤0.01% |
162,249
+25,329
| +18% | +$1.96M |
|
|
LFACU
3115
DELISTED
LF Capital Acquistion Corp. Unit
LFACU
| $12.9M | ﹤0.01% |
1,215,000
| – | – |
|
3116
Rush Enterprises Class B
RUSHB
$6.14B
| $12.8M | ﹤0.01% |
632,045
-822
| -0.1% | -$15.9K |
|
3117
Rafael Holdings
RFL
$107M
| $12.8M | ﹤0.01% |
729,448
+7,126
| +1% | +$130K |
|
3118
Angi Inc
ANGI
$196M
| $12.8M | ﹤0.01% |
151,064
-332,628
| -69% | -$24.8M |
|
|
RBNC
3119
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $12.8M | ﹤0.01% |
575,102
+3,232
| +0.6% | +$72.8K |
|
|
SIC
3120
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $12.8M | ﹤0.01% |
1,418,379
+85,024
| +6% | +$905K |
|
|
IGMS
3121
DELISTED
IGM Biosciences
IGMS
| $12.7M | ﹤0.01% |
333,079
+245,464
| +280% | +$6.17M |
|
|
TCRR
3122
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $12.7M | ﹤0.01% |
890,040
+60,221
| +7% | +$931K |
|
|
MFSF
3123
DELISTED
MutualFirst Financial Inc
MFSF
| $12.7M | ﹤0.01% |
320,446
+631
| +0.2% | +$23.3K |
|
|
ARA
3124
DELISTED
American Renal Associates Holdings, Inc
ARA
| $12.7M | ﹤0.01% |
1,220,694
-25,554
| -2% | -$219K |
|
3125
First Business Financial Services
FBIZ
$595M
| $12.6M | ﹤0.01% |
479,681
-1,124
| -0.2% | -$27.9K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.